At the recent American Association of Cancer Researchers (AACR,) there was a shocking poster presentation that demonstrated that mice that exercised experienced implanted prostate cancer tumor grow that was twice as fast than did those mice who were restricted from exercising! The study was conducted by the Duke Comprehensive Cancer Center (DCCC) and the Duke [...]
According to a report from Japan in the March issue of "Cancer Epidemiology, Biomarkers & Prevention", dietary isoflavones may reduce the risk of initially developing localized prostate cancer, but appear to be associated with advanced disease when prostate cancer does occur. This would explain the prior studies in which the consumption of soy by Japanese [...]
Federal Advocacy Update that you need to become involved with: There are three resolutions that NPCC is currently educating legislators about: H.Res 672 is sponsored by Doris Matui's office (CA-5) and it supports the goals and ideals of National Prostate Cancer Awareness Month in September. This resolution recognizes the main issues surrounding the lack of [...]
Are you taking Fosamax to help combat osteoporosis? Many of us take Fosamax as one of the most common side effects of a hormone blockade (ADT) is loss of bone density. ADT causes osteoporosis, or a decrease in bone density, which diminishes bone strength. A decrease in your bone density increases your chance to suffer [...]
Taxotere (chemotherapy for prostate cancer) is administered intravenously usually in an cancer center or a hospital setting. Often the areas which are designated for chemo administration are referred to as infusion centers. Taxotere is administered with either on a higher dosage schedule of once every three weeks (q3wk) or a lower dosage schedule of once [...]